{"nct_id":"NCT02184767","title":"Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2014-07","start_date_type":null,"primary_completion_date":"2015-03","primary_completion_date_type":"ACTUAL","completion_date":"2015-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TEVA"]}